INS and type 2 diabetes mellitus: Metabolic pathways included deregulated genes from the AMP-activated protein kinase (AMPK) pathway, gluconeogenesis as well as genes from insulin signaling, type II diabetes signaling, maturity onset diabetes of the young and circadian rhythm pathways.